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Without a cure, vaccination is the most reliable means of  combating COVID-19 pandemic, since non-pharmacological measures could 
not prevent its spread, as evidenced in the emergence of  a second wave. This study assessed the readiness of  pharmacists to receive, 
recommend and administer COVID-19 vaccines to clients in Nigeria.
Methods 
This was a cross-sectional study in which responses were collected from pharmacists in Nigeria through Google Form link. A 21-item 
questionnaire was developed and validated for the study. The link was shared on the WhatsApp groups of  eligible respondents. The 
response was downloaded into Microsoft Excel (2019) and cleared of  errors. This was uploaded into KwikTables (Beta Version 2021) 
for data analysis. Descriptive statistics such as frequencies and percentages were used to describe the data. Chi-squared test was used 
to determine the relationship between all the responses and the practice areas of  the pharmacists.
Results
A total of  509 pharmacists responded to the study, but 507 indicated their areas of  practice. The highest response of  247(48.7%) was 
obtained from hospital pharmacists, then community pharmacists; 157(31.0%). Hospital and community pharmacists accounted for 
96 and 66 of  the 191(37.7%) pharmacists that would probably accept the vaccine (p=0.126). The Pfizer-bioNTech vaccine was the 
preferred brand for 275(54.2%) respondents. Healthcare Professionals>Elderly>General Populace>Children was the order of  roll-out 
recommended by 317(62.5%). Adverse-effect-following-immunization was the concern of  330(65.1%) pharmacists. Age was a factor 
in their likelihood of  recommending the COVID-19 vaccine to clients (p=0.001).
Conclusion 
This study established that most pharmacists are willing to accept to be vaccinated against COVID-19, recommend and administer it 
to other citizens. They were impressed by the effectiveness and cost of  some of  the vaccines, but were concerned about their possible 
adverse effects. The pharmacists would want the authorities to consider strategies that will make the vaccines accessible to all citizens.
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Introduction
Nearly all the countries on the globe are battling a resurgence 
of  the COVID-19 infection, commonly termed the second 
wave of  the pandemic. The second wave, like the first, has 
stretched the healthcare facilities of  most nations, with many 
countries having a shortage of  pharmaceuticals for use in 
intensive care units, especially oxygen1. The global burden of  
the disease was reported by the World Health Organization 
to be 103,362,039, with a reported casualty of  2,244,713 
deaths as at 3rd February, 20212. Africa is not spared 
of  the challenges of  the second wave of  the pandemic 
as well3. With over a year gone since the declaration of  
COVID-19 as a pandemic, there is no research that has 
resulted in a definitive curative therapy for the disease4. 
Rather, symptomatic management has been employed by 
clinicians in reducing the fatality rate of  the disease5. The 
main strategies that have been used in the control of  the 
pandemic are non-pharmacological prophylactic measures. 
Examples of  such preventive strategies are social distancing 
and use of  facemasks with or without face shields when 
outdoor, avoidance of  touching the  mouth, nose and eyes, 
constant washing of  the hands with running water, among 
others6–8. These non-pharmacological measures seem not 
to be sufficient to prevent the spread of  the infection, as 
it is obvious from its resurgence after the lockdown orders 
in many countries were lifted. With the failure of  the non-
pharmacological measures, the use of  vaccines that can 
prevent the spread of  the disease is the obvious and more 
reliable alternative9. The use of  vaccines stand out as a better 
option, considering the fact that vaccines have proven to 
be successful in combating the horizontal transmission of  
communicable diseases10. 
With the roll-out of  some vaccines for use in the prevention 
of  COVID-19 in some countries11, the focus is now turning 
to the means of  getting the vaccines to the communities and 
the acceptance of  the vaccines by the populace. Healthcare 
professionals have an important role to play in getting the 
already available vaccines to the people. The acceptability 
of  the vaccines by the healthcare workers can serve as a 
boost on its own to the acceptance of  the vaccines by the 
general populace. Likewise, people trust their healthcare 
professionals and will be more accepting of  the vaccines on 
the recommendations of  their healthcare professionals. The 
administration of  the vaccines also rests with well-trained 
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healthcare professionals12.
Among the healthcare professionals, Pharmacists, especially 
those that practice in the community settings, have been 
reported to be the most accessible, even in primary 
healthcare13,14. In the administration of  vaccines, those of  
COVID-19 pandemic inclusive, pharmacists play such 
roles as maintenance of  the cold chain for the vaccines, 
administration of  the vaccines, provision of  pharmaceutical 
care services to clients, and involvement in the training of  
colleagues15. The provision of  COVID-19 vaccines will 
require the involvement of  all healthcare professionals, 
irrespective of  their practice settings. This is because the 
eradication of  the pandemic will require the vaccination of  
every member of  the society. Hence, the participation of  
pharmacists will require that practitioners from the hospitals, 
community practice, industry, academia and even those that 
are in administration and other non-pharmacy areas. It is 
pertinent to note that the currently available vaccines may 
not be enough to reach everybody in the community. Thus, 
it would be study-worthy to know the perception of  these 
critical healthcare professionals about the vaccines.
Aim of the study 
The objective of  this study was to assess the readiness of  
pharmacists to be vaccinated against COVID-19 as well as 
their recommendation and administration of  the vaccines to 
clients, irrespective of  their practice areas.
Ethics Approval
An institutional review board approval was obtained from the 
Research Ethics Committee of  the Faculty of  Pharmaceutical 
Sciences of  the University of  Nigeria  (FPSRE/
UNN/20/00312), although the study did not involve the use 
of  specific patients of  a disease. No identifier information 
was obtained from the respondents, just as confidentiality 
was maintained throughout the study. Respondents’ consent 
to participate in the study was obtained by requesting them 
to compulsorily indicate their willingness to participate in the 
study after explaining the purpose of  the study to them at 
the beginning of  the questionnaire.
Methods
Design
This was a cross-sectional study in which responses were 
collected online from respondents through Google Form 
links.
Study Settings and Participants
This study was conducted among registered pharmacists 
in Nigeria. The study included all pharmacists including 
those that are not practicing. This was because, in a 
pandemic, health authorities could choose to involve all 
qualified personnel in their public health activities (such as 
recommendations and administration of  vaccines) even if  
those that are not practicing would require short refresher 
courses. With a population of  over 250 million as at 2020, 
Nigeria is the most populous country in Africa and accounts 
for the largest population of  black people in the world. The 
Nigerian Centre for Disease Control (NCDC) reported 
that as at 3rd February 2021, there were 134,690 cases of  
COVID-19 infections confirmed in Nigeria 16. Although the 
fatality rate has been low so far, with the number of  infected 
persons who died from COVID-19 disease being 1,618, 
an uncontrolled infectious rate of  COVID-19 in Nigeria 
poses a risk not only to the African continent but to the 
whole world. Apart from the issue of  Nigerians travelling to 
and fro different countries, the country shares border with 
about four countries: the borders are porous and difficult to 
control by health officials. Pharmacists in Nigeria practise in 
community pharmacies, hospitals, educational and research 
institutions, non-governmental organizations, administrative 
offices, and pharmaceutical industries. There were about 
15000 registered pharmacists in Nigeria in 2020, majority of  
who practice in the community and hospitals settings. 
Study Instrument
A 21-item questionnaire was developed and validated for 
the study. Section A had nine items and inquired about 
respondents’ characteristics. Section B contained 10 questions 
and assessed the respondents’ likelihood (viz.: definitely not, 
probably and certainly) of  receiving, recommending and 
administering COVID-19 vaccines as well as the preferred 
order of  recipients of  the vaccines. Section C comprised a 
single item which measured the respondents’ choice vaccine 
and their perceived concerns about the currently available 
vaccines. The questions in the questionnaires were developed 
from extensive search in paper and electronic literatures. 
Content validation was done by a group of  experts at the 
University of  Nigeria while face validation was conducted 
using 10 pharmacists who were excluded from the main 
study’s data collection. The final instrument was adopted 
after obtaining an acceptable Cronbach’s alpha value of  0.89.
Data Collection Procedure
The eligibility criterion considered for participation in this 
study was that respondents were consenting registered 
pharmacists residing and practising in Nigeria at the time of  
the study. Using Raosoft online sample size calculator with 
a margin of  error set at 5% and a confidence interval of  
95%, the minimum number required for the study sample 
to be a true representation of  the population was 377, with 
the researchers giving an allowance of  10%. The study 
instrument was converted into a Google Form and the link 
was shared on the WhatsApp groups of  the national groups 
of  pharmacists in Nigeria. Periodic reminder messages 
containing the same link to the online form were sent to 
the individual WhatsApp accounts of  the Pharmacists in 
the groups. The use of  WhatsApp in collecting data was to 
checkmate response from non-pharmacists, as the WhatsApp 
platforms have administrators that screen participants before 
including them. However, respondents were requested not to 
share the link with any other person. The use of  WhatsApp 
also afforded the researchers the ability to determine the 
number of  participants that actually read the message that 
requested them to complete the study questionnaire. In 
addition, the use of  national associations’ platforms would 
allow the generalization of  the findings, as members from all 
regions of  the country across all ages would be reached. At 
the end of  the three-week data collection period, the link was 
disabled from collecting responses.
Data Management and Analysis
The recorded responses in the Google document was 
downloaded into Microsoft Excel (2019) and cleared of  
errors. This was uploaded into KwikTables (Beta Version 
2021) for data analysis. Descriptive statistics such as 
frequencies and percentages were used to describe the data. 
In the presentation of  the results, Chi-squared test was 
used to indicate the relationship between all the responses 
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and the practice areas of  the pharmacists. Thereafter, the 
socio-demographic characteristics that were related with 
the likelihood responses were identified. For all statistical 
analyses, p values less than 0.05 were considered to be 
significant.
Results
The study had a high response rate that exceeded the target 
sample size. A total of  509 pharmacists from different 
practice settings responded to the questionnaire, but 507 
indicated their areas of  practice. The highest response of  
247 (48.7%) was obtained from pharmacists practising in the 
hospitals, closely followed by 157 (31.0%) from pharmacists 
in community practice. The respondents were almost age-
balanced for ages below 60 years: 253 (49.9%) for those 
less than 30 years and 245 (48.3%) for those aged between 
30 and 60 years. But the age distribution varied across 
practice settings (p=0.006). About half, 249 (49.1%), of  the 
respondents were single, while 362 (71.4%) did not have an 
additional postgraduate pharmacy degree (p≤0.0001) and 
283 (55.8%) had practised for less than six years (p=≤0.0001). 
Complete information about the respondents’ characteristics 
is in Table 1.
Out of  the 507 pharmacists, 191 (37.7%) indicated that they 
would probably accept to be immunized with the COVID-19 
vaccine. Hospital and community pharmacists accounted 
for 96 (50.26%) and 66 (34.55%) of  the 191 pharmacists 
that would probably accept the vaccine, with the least report 
being from pharmacists that serve in pharmacy-related 
non-governmental organization (p = 0.126). There were no 
significant relationships between the practice areas of  the 
pharmacist and the choices of  likelihood of  receiving (p = 
0.126).
While 216 (42.6%) of  the pharmacists would probably 
recommend the COVID-19 vaccine to their family 
members, 222 (43.8%) would probably recommend same 
to their clients. Practice settings did not have a relationship 
with the choice of  recommending the vaccines for family 
members (p = 0.221), although it did have a relationship with 
recommending for clients (p = 0.017).  
Hospital pharmacists were 112 (46.23%) of  242 respondents 
that would certainly administer the vaccines to citizens if  
they are permitted to do so. A total of  90 (17.8%) indicated 
that they would definitely not administer the vaccines to 
citizens if  they are asked to do so. Practice settings of  the 
pharmacists played a vital role in the likelihood of  accepting 
to administer the vaccines to citizens (p = 0.048). Table 
2 has the results of  the Pharmacists’ readiness to receive, 
recommend and administer COVID-19 vaccines. 
Out of  the three COVID-19 vaccines with emergency use 
permission, 275 (54.2%) of  the Nigerian pharmacists in 
the study preferred the Pfizer-bioNTech brand the most. 
Out of  the 157 community pharmacists, 91 indicated a 
preference for Pfizer-bioNTech brand while 15 of  33 
academic pharmacists preferred the same brand (p = 0.746). 
The main reason for the preference for Pfizer-bioNTech 
brand by the pharmacists was effectiveness, indicated by 
194 (38.3%). On the recommended order of  roll-out of  
the vaccines, 317 (62.5%) pharmacists chose Healthcare 
Professionals>Elderly>General Populace>Children, with 20 
of  the 33 academic pharmacist and 14 of  the 18 pharmacists 
who do not work in a pharmacy area choosing the option (p 
= 0.157). (Table 3)
For the perceived concerns about the COVID19 vaccines, 
the fear of  “adverse effect following immunization” was 
expressed by 330 (65.1%) pharmacists. No pharmacist 
feared that they could be infected with COVID-19 by the 
vaccine. Although 105 (20.7%) pharmacists reported that 
they were concerned that the development of  the vaccines 
did not follow standard scientific procedure, pharmacists 
practising in the academia accounted for only two (p = 
0.326). Twelve pharmacists expressed fears that were not 
listed in the questionnaire, such as the availability of  cold 
chain for the vaccines and the use of  mRNA technology. 
Table 4 documents all the perceived concerns of  Nigerian 
pharmacists about the COVID-19 vaccines.
Age was the sociodemographic factor that had a statistically 
significant relationship with the two variables of  likelihood 
to receive the COVID-19 vaccine by self  (p = 0.011) and 
for clients (p = 0.001), as younger pharmacists were more 
likely to accept, recommend and administer the vaccine. 
Of  all ages, 111 (21.8%), 131 (25.7%), and 99 (19.4%) 
respondents who were less than 30 years would probably 
accept the vaccine, recommend it to clients, and administer 
it to citizens, respectively. Definitely not was the response of  
166 (32.6%) of  pharmacists of  all ages for accepting to be 
vaccinated while 222 (43.6%) respondents of  all ages would 
probably recommend the vaccines to their clients. Years of  
experience had a significant relationship with the likelihood 
of  recommending the vaccines for clients (p = 0.038), with 
222 (43.6%) reporting that they would probably recommend 
it. The relationship between the sociodemographic 
characteristics and the likelihood of  receiving, recommending 
and administering the vaccines are indicated in Table 5.
Discussion
This study evaluated the willingness of  pharmacists in 
different practice settings in Nigeria to accept to be vaccinated 
with the available COVID-19 vaccines, as well as their 
readiness to recommend and administer the vaccines to fellow 
citizens. More than half  of  the pharmacists that responded 
to the study questionnaire practise in the hospitals and 
community pharmacies, while majority of  the respondents 
were in the ages of  active service. The main reason for the 
unequal distribution could be that employments in those 
settings (especially the community pharmacies) are driven 
by the private sectors, unlike most others that would require 
employment in limited government facilities. Nonetheless, it 
is a strength to the study, as most pharmacists that would 
actually recommend and administer vaccines practice in the 
community and hospital pharmacies.
Principal Findings
The study findings showed that majority of  the respondents 
would accept to be administered the available COVID-19 
vaccines, although the level of  acceptance varied between 
the different areas of  practice. The respondents expressed 
similar positions in their willingness to recommend the 
vaccines to their family members, friends and fellow 
healthcare workers. However, their practice area played a role 
in their likelihood of  recommending the vaccines to clients 
who seek their professional advice and their willingness to 
be involved in the administration of  COVID-19 vaccines 
to citizens. Majority of  the pharmacists that practise in the 
hospitals and community setting were willing to recommend 
and administer the vaccines to their clients. This could be 
attributed to the routine service delivery to clients that those 
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since the adults are the guardians and hold the consent for 
the infants. It would however require that they are reimbursed 
for such exercises, while every negative perception of  their 
participation by other healthcare providers is cleared with 
due sensitizations. It must be noted that studies have proved 
that fellow healthcare workers in most communities, as well 
as the public, have accepted that pharmacists’ roles should be 
expanded to include participation in immunization activities. 
Still in Canada, MacDougall et al. reported that the public 
and other healthcare providers have a good perception 
about pharmacists’ participation in routine immunization21. 
One aspect of  participation in immunization exercise that 
the respondents in the study rated the pharmacists to be 
high was that the pharmacists could be trusted for reliable 
information about immunization. The onus is thus on the 
policy makers so ensure that the respondents in the current 
study are well informed about the COVID-19 vaccines, 
since many of  them reported that they did not have 
enough information about them, but would be willing to 
be trained. When pharmacists’ involvement in vaccination 
was instituted in Western Australia, a study by Hattingh et 
al. reported that vaccine delivery by pharmacists was safe22. 
They further recommended that the scope of  pharmacy 
practice should be expanded to include involvement in 
routine vaccination exercises which should be done with 
appropriate remuneration. 
In Nigeria, pharmacists have not been involved by 
government in any form of  community immunization 
programme, apart from storage and delivery of  the vaccines. 
Oluwadamilola reported in a conference paper that almost 
all the community pharmacists that she contacted in Lagos, 
Nigeria, were willing to be trained and licensed to administer 
routine vaccines to the citizens23. Agbo et al. also reported 
from Cross River State, Nigeria, that the only form of  
immunization that community pharmacists were involved in 
was client-requested prophylaxis that required dispensing of  
tetanus toxoid, rabies vaccines, and hepatitis B vaccine24. The 
pharmacists who responded to the study however expressed 
the readiness to participate in broader immunization services 
when they are permitted to do so by the appropriate authority.
The role of  pharmacists in immunization exercises is 
further brought to the forefront when the ‘3 Cs’ of  vaccine 
hesitancy identified by the World Health Organization 
are considered in the light of  global COVID-19 vaccines 
hesitancy, especially in Africa25–27. Confidence, complacency 
and convenience are concepts that are easily resolved with 
the use of  pharmacists, since majority of  them serve as 
primary care providers, as proven by this study. In African 
countries, pharmacists are often contacted for healthcare 
services by the people, primarily because they may not need 
any form of  booking for appointments. The continuous 
interactions over time confers the reputation of  trust on 
the pharmacists, thus the opportunity to provide verified 
information about the vaccines, while dispelling commonly-
held myths28. Provided the pharmacists are vaccinated, 
they would be in the right position to advise and vaccinate 
their clients with COVID-19 vaccines. As a statement 
by the American Pharmacists Association revealed, the 
confidence level of  the pharmacists increased overtime 
with their gradual inclusion in COVID-19 vaccines29. This 
study thus believes that most African countries will attain a 
very good COVID-19 vaccination coverage if  they involve 
their pharmacists. Pharmacists are already underutilized in 
COVID-19 response, considering their trainings30, despite 
groups of  pharmacists engage in daily in their practice. In 
addition, they have the opportunity of  directly being in 
contact with persons that have been diagnosed with the 
disease and would, thus, appreciate the value of  vaccination 
against COVID-19 infection. The COVID-19 vaccine 
that was produced by Pfizer-BioNTech had the highest 
acceptability of  the three that are currently in use in most 
countries by pharmacists in Nigeria. Among the three options 
that were provided to the respondents as possible reasons 
for the choice of  the preferred vaccine, the Pfizer-BioNTech 
vaccine did not report the highest level of  effectiveness, 
but the respondents still chose it. This could be explained 
from their choices of  other reasons, as the duo of  storage 
condition and cost of  the vaccine was the second reason that 
was preponderant among the pharmacists to account for their 
choice of  the particular vaccine. It is noted that the vaccines 
are provided to the citizens at no cost, just as the government 
is also obtaining it at no cost from donor organizations at the 
moment. It is, however, obvious that the government may 
not be able to reach its over 200 million citizens with the free 
provision of  the vaccines. Thus, the cost of  the vaccines is an 
important variable, especially if  the government would want 
to purchase the vaccines. The pharmacists in this study prefer 
that healthcare professionals should be given the highest 
priority in rolling out the vaccines, followed by the elderly 
citizens, then the general populace. This is an understandable 
choice in the order of  administering the drugs. Vaccinating 
health workers, especially those that are at the front line of  
providing healthcare services to the people will ensure that 
every society has a reservoir of  healthy and fit health service 
providers. This is in addition to safeguarding the healthcare 
workers who are at a risk of  being infected with the disease 
by clients who seek their professional service. Many concerns 
were expressed by the pharmacists about the COVID-19 
vaccines, but no choice had a relationship with their areas 
of  practice. This implies that they had equal level of  fear 
that informed the reasons why some may neither receive the 
vaccine nor recommend it to others. The respondents were 
most concerned about possible adverse effects that could 
result from the vaccination, even though specific adverse 
effects were not mentioned. Perhaps, when they are informed 
about the adverse effects and the ways of  managing them, the 
likelihood of  receiving and recommending the vaccine may 
be higher. Accessibility of  the vaccines by all citizens was 
understandably a concern of  many respondents, considering 
that many essential pharmaceuticals do not get to rural areas 
where majority of  the citizens reside. The highest degree 
of  likelihood was reported by the elderly respondents to 
receiving and recommending the vaccine. With the higher 
chance of  being infected with the disease and high mortality 
rate in that age category, the result was expected.
Comparison with Previous Studies 
The accessibility of  pharmacists to clients in every community 
is commonly reported in literatures17–19. Health promotion 
campaigns succeed very well when they are involved, especially 
the pharmacists that practise in community premises14,15. 
Their willingness to participate in vaccination exercises have 
been reported in many studies. In a survey that was conducted 
in 2015 among community-based pharmacists in Canada, 
Edwards et al. found out that community pharmacists were 
willing to participate in immunization activities if  they were 
licensed, after appropriate training, to do so20. Although 
the study focused on adult immunization, an acceptance to 
participate in infant immunization could also be construed, 
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their willingness to participate in public health activities 
including COVID-19 testing31. In Nigeria, the pharmacists 
that are most likely to be involved in immunization exercise 
are the community and hospitals pharmacists. They are 
already currently involved in a weekly clinical training 
exercise on an array of  topics under the auspices of  the 
newly-formed Clinical Pharmacists’ Association of  Nigeria 
(CPAN). By that singular practice, CPAN empowers them to 
be prepared for any clinical service, including the COVID-19 
vaccination.   
Policy Implications
The current study in a developing country provides a 
lot of  information to governments, multinational health 
service funders and other policy makers on the rollout of  
the COVID-19 vaccines. Pharmacists play a lot of  roles in 
the society, and with the findings that they would want to 
participate in the activities concerning the vaccinations, the 
appropriate authorities should carry them along. 
Strengths and Limitations
No study in the literatures has documented the willingness 
of  pharmacists to receive, recommend or administer 
COVID-19 vaccines to citizens in any country. Researchers 
have, however reported that pharmacists are willing to 
participate in any COVID-19 response activity that they 
are requested to perform. In a study conducted in Idaho, 
United States, Nguyen et al. observed that about 70% of  
the 229 pharmacists that responded to their study questions 
were willing to provide COVID-19 testing service to their 
community30. The pharmacists did mention in the study 
that possible motivators to their full involvement in the 
COVID-19 response were institution of  reimbursement 
modalities, recruitment of  sufficient manpower and 
organization of  work schedule to accommodate their 
involvement. A systematic review by Lee et al. in reputable 
databases observed the underutilization of  pharmacists in 
the COVID-19 response31. They concluded that pharmacists 
will have a lot of  roles to play in the roll out of  mass 
immunization against COVID-19.
This study was conducted using WhatsApp social media 
accounts and that assisted in obtaining the high response rate. 
The mode of  data collection could, however, be a limitation, 
as some eligible respondents might have been offline at 
the time that the link to the questionnaire was shared. The 
use of  WhatsApp also predisposed the study to the risk of  
having non-eligible persons accessing the study link due to 
the possibility of  hacking of  the WhatsApp contacts or use 
of  the WhatsApp device with third parties. The limitation 
is common with online surveys, though the instrument of  
the present study had an opening remark that requested 
non-eligible persons not to respond to the questionnaire. 
In addition, at the time that the study was conducted, no 
COVID-19 vaccine was available in Nigeria: it is possible that 
their responses may be different if  the reverse was the case. 
The timeframe of  data collection was short, although it was 
done that way because of  the urgency of  the contribution that 
the study findings will have to policymakers in determining 
how the COVID-19 vaccines will be deployed. A long-time 
frame would also affect the response as the perceptions of  
people may change overtime in a pandemic. Also, using a 
short timeframe was a form of  checkmating abuse of  the 
link being shared to non-eligible persons. The study did not 
request the participants to indicate their states of  residence, 
thus limiting the ability to determine their region of  practice. 
Nonetheless, the collation of  their areas of  practice gives an 
idea that they practice in different regions of  the country.
Conclusion
This study established that most pharmacists, irrespective of  
their practice settings are willing to accept to be vaccinated 
with the currently available COVID-19 vaccines. Majority of  
them expressed the readiness to recommend and administer 
the vaccines to their family members, friends, fellow 
healthcare professionals and clients who seek their advice. 
They were impressed by the effectiveness and cost of  some 
of  the vaccines, but were concerned about the possible 
adverse effects of  the vaccines. The pharmacists would 
want the authorities to consider strategies that will make the 
vaccines accessible to all citizens. 
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